RSS Alerts

Related Links

Related Stories

News

Key appointment for Sartorius

12 June 2009

Sartorius Stedim Biotech North America Inc. has appointed Dr. Yujing Yang as director of Purification Technologies, North America.

Sartorius Stedim Biotech says he brings broad experience in all areas of biopharmaceutical downstream processing and in-depth knowledge of biotech-related technologies, such as Xflow filtration and membrane chromatography, to Sartorius Stedim Biotech. In his current position, Dr. Yang reports to Dr. Uwe Gottschalk, vice-president of Marketing, Purification Technologies. Dr. Yang obtained both his Bachelor’s and Master’s degrees in Engineering from Tsinghua University in Beijing, China, and earned his Ph.D. in Environmental Biology at the University of Massachusetts in Boston, where he conducted research on cloning and won a number of awards.
Before joining Sartorius Stedim Biotech, Dr. Yujing Yang was Industrial Commercial Leader for Life Sciences in Greater China at GE Healthcare, where he was responsible for marketing, sales and support teams. Prior to assuming this position, he was Technical Marketing director for Asia, and held various positions in business development, product management, application and technical support. Dr. Yang, who has been working in the field of biopurification for twelve years, was employed in various management and research positions at Pall Corporation, the U.S. National Research Council and the Boston Biomedical Research Institute. He also taught as an Assistant Professor for three years at Tsinghua University and has four bioprocessing patents to his name.

 

This article is featured in:
Pharma and biotech

 

Comment on this article

You must be registered and logged in to leave a comment about this article.

Copyright © 2010
Elsevier Ltd. All rights reserved.
Terms & Conditions | Privacy | Website Design Working with water